NCT03861520 is a clinical trial of Midtrimester anomaly scan in Soft Markers, sponsored by Cairo University.

Who is sponsoring NCT03861520?

NCT03861520 is sponsored by Cairo University.

What drugs are being tested in NCT03861520?

Interventions in NCT03861520: Midtrimester anomaly scan, Fetal Karyotyping.

What condition does NCT03861520 study?

NCT03861520 studies Soft Markers.

Is NCT03861520 still recruiting?

NCT03861520 is currently completed. Last updated 7 April 2020.

Last reviewed 2020-04-07 · How we verify

NCT03861520

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ultrasonographic Fetal Soft Markers and Aneuploidy

Completed Last updated 7 April 2020

What this trial tests

trial testing Midtrimester anomaly scan in Soft Markers in 100 participants. Completed in 5 April 2020.

Timeline

14 March 2019

Primary endpoint
5 April 2020

5 April 2020

Quick facts

Lead sponsor	Cairo University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	100
Start date	14 March 2019
Primary completion	5 April 2020
Estimated completion	5 April 2020
Sites	1 location across Egypt

Drugs / interventions tested

Midtrimester anomaly scan
Fetal Karyotyping

Conditions studied

Soft Markers — all drugs for Soft Markers →

Sponsor

Cairo University

Who can join

Adults 20 to 40, female only, with Soft Markers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the prevalence of soft markers which will be identified during a second trimester ultrasound. Secondary aims were to estimate the association between the soft markers and trisomies 13, 18 and 21 as well as the effect on the number of invasive tests will be performed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03861520 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 7 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03861520.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing